MARKET

NEO

NEO

Neogenomics Inc
NASDAQ
7.31
-0.24
-3.18%
Closed 16:20 07/07 EDT
OPEN
7.46
PREV CLOSE
7.55
HIGH
7.62
LOW
7.27
VOLUME
1.51M
TURNOVER
0
52 WEEK HIGH
19.12
52 WEEK LOW
6.08
MARKET CAP
940.76M
P/E (TTM)
-11.9660
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NEO last week (0630-0704)?
Weekly Report · 1d ago
Press Release: NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
Dow Jones · 07/01 11:18
NeoGenomics Announced The Launch Of PanTracer Tissue, A Next-generation Solid Tumor Profiling Assay, Including The Option To Add Testing For Homologous Recombination Deficiency
Benzinga · 06/30 11:15
Weekly Report: what happened at NEO last week (0623-0627)?
Weekly Report · 06/30 11:08
NEOGENOMICS ANNOUNCES PANTRACER TISSUE AND PANTRACER TISSUE + HRD NOW AVAILABLE TO SUPPORT MORE INFORMED AND TIMELY CANCER CARE
Reuters · 06/30 11:05
AMG GW&K Small Cap Value Fund Q1 2025 Commentary
Seeking Alpha · 06/26 03:20
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
Benzinga · 06/25 19:16
Bank of America Securities Reaffirms Their Hold Rating on NeoGenomics (NEO)
TipRanks · 06/25 10:17
More
About NEO
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Webull offers NeoGenomics, Inc. stock information, including NASDAQ: NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.